TRAIL antibody (C-Term)
Quick Overview for TRAIL antibody (C-Term) (ABIN2877902)
Target
See all TRAIL (TNFSF10) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Recognizes the 32kD apoptosis related protein designated TRAIL (TNF-related apoptosis-inducing ligand) and also as Apo-2L. TRAIL is a type II membrane protein expressed in a variety of tissues. Receptors for TRAIL have recently been identified and termed DR4 and DR5.
-
Purification
- Ion exchange chromatography
-
Immunogen
-
Peptide from C-terminus of human TRAIL.
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: WB (1:500)
Usage: Western Blot: 1:500. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- TRAIL (TNFSF10) (Tumor Necrosis Factor (Ligand) Superfamily, Member 10 (TNFSF10))
-
Alternative Name
- TNFSF10 / TRAIL
-
Background
-
Name/Gene ID: TNFSF10
Family: TNF
Synonyms: TNFSF10, Apo-2L, APO2L, Apo-2 ligand, CD253, CD253 antigen, TRAIL, Protein TRAIL, TL2 -
Gene ID
- 8743
-
UniProt
- P50591
-
Pathways
- Apoptosis, Positive Regulation of Endopeptidase Activity
Target
-